期刊文献+

利用Caco-2细胞单层模型评价P-糖蛋白对安妥沙星转运的影响

Evaluation of P-gp on the transport of antofloxacin by using Caco-2 cell monolayer model
下载PDF
导出
摘要 目的评价P-糖蛋白抑制剂酮康唑对安妥沙星转运的影响。方法利用人源结肠腺癌系Caco-2细胞单层模型对安妥沙星进行双向转运,采用高效液相色谱法对安妥沙星进行定量分析,计算其表观渗透系数(Papp)。结果加入酮康唑后,低浓度安妥沙星(100μmol/L)Papp(B-A)/Papp(A-B)由4.12降至1.23(P<0.01),高浓度安妥沙星(500μmol/L)Papp(B-A)/Papp(A-B)由3.54降至1.22(P<0.01)。结论安妥沙星在Caco-2细胞单层模型中的转运机制可能以主动转运为主,P-糖蛋白参与其从细胞基底侧向管腔面的分泌。 Objective To evaluate the effect of P-gp inhibitor ketoconazole on the transport of antofloxacin by using human colon adenocarcinoma line Caco-2 cell monolayer model. Methods The concentrations of antofloxacin collected from the transport assay were determined by high performance liquid chromatography and the transport parameters such as apparent permeability coefficient[Papp (A-B) and Papp (B-A)] and the ratio of Papp (B-A) versus Papp (A-B) were calculated and compared when the antofloxacin was used sololy and co-used with ketoconazole. Results When ketoconazole was present, the Papp (B-A)/Papp (A-B) of antofloxacin decreased from 4.12 to 1.23 and 3.54 to 1.22 at the concentration of 100μmol/L and 500μmol/L, respectively. And Papp (B-A) were also decreased obviously at each concentration level, from 4.23±0.27 to 2.39±0.70 and 8.49±0.89 to 5.03±1.20. Conclusion The reasults indicated that active transport might play a major role in the transport of antofloxacin in Caco-2 cell monolayer model and P-gp involved in the secretion of antofloxacin from basolateral to apical.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2011年第6期465-467,I0001,共4页 Chinese Journal of Antibiotics
基金 北京大学综合性创新药物研究开发技术大平台的建设(2009ZX09301-010)
关键词 CACO-2细胞单层模型 安妥沙星 表观渗透率 Caco-2 cell monolayer model Apparent permeability coefficient(Papp) Antofloxacin
  • 相关文献

参考文献7

  • 1蔡润兰,王敏,齐云,王翔岩,谢忱,罗秀珍.Caco-2细胞模型验证指标的选择与评判[J].中国药学杂志,2008,43(24):1871-1875. 被引量:30
  • 2Yoo H H,,Lee M,Chung H J,et al.Effects of diosmin,a flavonoid glycoside in citrus fruits,on P-glycoprotein-mediated drug ef?ux in human intestinal Caco-2cells. Journal of Agricultural and Food Chemistry . 2007
  • 3Yamaguchi H,,Yano I,Hashimoto Y,et al.Secretory mechanisms of grepafloxacin and levo?oxacin in the human intestinal cell line Caco-2. Journal of Pharmacology and Experimental Therapeutics . 2000
  • 4Xiao YH,Lv Y,Kang ZS,et al.Tolerability and pharmacokinetics of antofloxacin hydrochloride after multiple oral dose administration in healthy Chinese male volunteers. International Journal of Clinical Pharmacology Research . 2008
  • 5Sorgel F,Naber KG,Jaehde U,et al.Gastrointestinal secretion of ciprofloxacin. The American Journal of Medicine . 1989
  • 6Cormet-Boyaka E,Huneau JF,Mordrelle A,et al.Secretion of sparfloxacin from the human intestinal Caco-2 cell line is altered by P-glycoprotein inhibitors. Antimicrobial Agents and Chemotherapy . 1998
  • 7Hidalgo IJ,Raub TJ,Borchardt RT.Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology . 1989

二级参考文献24

  • 1关溯,赵立子,陈杰,陈孝,黄民.Caco-2细胞模型的建立及意义[J].山东医药,2005,45(26):1-3. 被引量:10
  • 2SUSSMAN N L, ELIAKIM R, RUBIN D, et al. Intestinal alka- line phosphatase is secreted bidirectionally from villous enterocytes [ J ]. Am J Physiol, 1989,257 ( 1 Pt 1 ) : 14-23.
  • 3YU H, COOK T J, SINKO P J. Evidence for diminished functional expression of intestinal transporters in Caco-2 cell monolayers at high passahes[J]. Pharm Res, 1997, 14(6) :757-762.
  • 4MARKOWSKA M, OBERLE R, JUZWIN S, et al. Optimizing Caco-2 cell monolayers to increase throughput in drug intestinal absorption analysis [J].J Pharmacol Toxicol Methods, 2001, 46 (1) :51-55.
  • 5YU H, SINKO P J. Influence of the microporous substratum and hydrodynamics on resistances to drug transport in cell culture systems: calculation of intrinsic transport parameters [ J ]. J Pharm Sci, 1997, 86(12) :1448-1457.
  • 6TUCKER S P, MELSEN L R, COMPANS R W. Migration of polarized epithelial cells through permeable membrane substrates of defined pore size [ J ]. Eur J Cell Biol, 1992, 58 ( 2 ) : 280- 290.
  • 7GEYS J, NEMERY B, HOET P H. Optimisation of culture conditions to develop an in vitro pulmonary permeability model [J].Toxicol In Vitro, 2007, 21 (7):1215-1219.
  • 8NARAI A, ARAI S, SHKIMIZU M. Rapid decrease in transepithelial electrical resistance of human intestinal Caco-2 cell monolayers by cytotoxic membrane perturbents [ J ]. Toxicol In Vitro, 1997, 11:347-354.
  • 9AIBA T, ISHIDA K, YOSHINAGA M, et al. Pharmacokinetic characterization of transcellular transport and drug interaction of digoxin in Caco-2 cell monolayers [ J ]. Biol Pharm Bull, 2005, 28(1) :114-119.
  • 10KONSOULA R, BARILE F A. Correlation of in vitro cytotoxicity with paracellular permeability in Caco-2 cell [ J ]. Toxicol In Vitro, 2005, 19(5) :675-684.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部